The Prevalence of Chronic Critical Illness in Turkey

Chronic Critical Illness Clinical Trial

Official title:

The Prevalence of Chronic Critical Illness Adult Intensive Care Units in Turkey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03262883
• Other study ID #: Chronic critical illness
• Status: Completed
• Start date: September 1, 2017
• Est. completion date: April 28, 2019

Study information

• Verified date: October 2019
• Source: Yuzuncu Yil University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is known that the number of Chronic Critical İllnes, an iatrogenic condition, increases all over the world. The prevalence of Chronic Critical Illness in Turkey is unknown. The investigators aimed to evaluate the etiology, comorbid conditions, demographic data, prevalence, mortality and costs of these patient in intensive care units in Turkey. In this multi-centered study, The investigators will retrospectively review the last 1 year of patients receiving treatment at the Adult Intensive Care Unit.

Description:

The patients who survive an acute critical illness in the Intensive Care Unit (ICU) may be delayed in a situation where they are sometimes totally independent before hand due to iatrogenic causes such as infections, dysfunctions, psychological disorders. This can take weeks, sometimes months. This disease is called "Chronic Critical Illness" (CCI).

Most researchers associate CCI with the need for prolonged acute mechanical ventilation or the opening of tracheostomy for prolonged acute mechanical ventilation. There is no single condition that does not require an extended mechanical ventilation from CCI. In conclusion, CCI is characterized by long-term care requiring survival and it is predicted that the cost of these patients will increase with the new patients whose cost will be added in the coming years. In the United States, the number of CCI is around 250,000, and this figure has increased by 50-100% in the last 10 years. At least 50% of these patients die in one year and less than 12% recover and become discharged. The annual cost of these patients' health care system is over $ 20 billion. The prevalence of CCI in Turkey is still unknown. In this study, it was aimed to investigate the prevalence of patients with Chronic Critical Syndrome in intensive care units in Turkey.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2493
• Est. completion date: April 28, 2019
• Est. primary completion date: December 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

The patient who is over 18 years old, taking mechanical ventilation support and staying in the critical care unit at least 8 days. Additional criterias; Clinical diagnosis of following situations:

1. Prolonged mechanical ventilation

2. Tracheotomia

3. Sepsis

4. Serious injury (burn)

5. Stroke ( hemorhagic or ischemic)

6. Traumatic brain injury

Exclusion Criteria:

1. The patients who not having mechanical ventilation support

2. The patient staying less than 8 days in the intensive care unit

3. The patient younger than 18 years old

Related Conditions & MeSH terms

• Chronic Critical Illness
• Critical Illness

Locations

Country	Name	City	State
Turkey	Yuzuncu Yil University	Van

Sponsors (3)

Lead Sponsor	Collaborator
Yuzuncu Yil University	Izmir Ataturk Training and Research Hospital, Kahramanmaras Sutcu Imam University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Critical care unit mortality	The mortality change rates in the 30th days and 90th days	30 day and 90 day
Secondary	Critical care unit costs	Costs of patients staying in the intensive care unit	Duration of intensive care unit stay (8 day after the hospitalisation to sixth month)